ADTXOTCPharmaceutical PreparationsFiscal year ends December 31
Aditxt, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026
- Market cap
- $20
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7,959.4478 (−100.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Aditxt, Inc. saw revenue fall 74.1% to $14.34K over the twelve months to Mar 31, 2026. Free cash flow was -$25.70M.
Revenue
$14.34K
-74.1% vs. a year earlier
Operating income
-$18.32M
TTM Q1 2026
Free cash flow
-$25.70M
FY2025
EPS, diluted
-$1153.83
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $20
- P/E ratio
- –
- Price to sales
- 0.00
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -127402111.63%
Fundamentals
- Revenue
- $14.34K
- Net income
- -$53.34M
- EPS, diluted
- -$1153.83
- Free cash flow
- -$25.70M
- Book value per share
- -$1649.49
- Diluted shares
- 0M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$14.34K-74.1% YoY
Gross profit
$2.85K
Operating income
-$18.32M
Net income
-$53.34M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months